Clinical trial

Montelukast Therapy on Alzheimer's Disease

NCT03991988

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-09-25

PhasePHASE2

Study timeline

Study start (actual)2019-09-25Date precision: day

Registry last updated2024-03-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

MontelukastDRUG · verified · RxNorm: montelukast

Placebo oral tabletDRUG

Sponsors & collaborators

Emory Universitylead sponsor

Mapped research locations

AtlantaGeorgia, United States4

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03991988 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.